JAMA Network

•

チャンネル • 21個の番組

医学

医学

アップデート：毎週
医学

医学

アップデート：隔週
医学

医学

1月8日
医学

医学

アップデート：月2回
医学

医学

アップデート：毎月
医学

医学

3月9日
医学

医学

アップデート：毎月

3月9日

Obesity-Related Cancer

Overweight and obesity may cause 10% of new cancer diagnoses annually in the US. In this JAMA Review in the Translational Science series, author Neil Iyengar, MD, of Emory University discusses the biological pathways that may promote cancer in people with overweight or obesity and potential therapies with JAMA Deputy Editor Mary McDermott, MD. Related Content: Obesity and Cancer

3月9日

•

21分
3月2日

Diagnosis and Treatment of Chronic, Noninfectious Diarrhea

Chronic noninfectious diarrhea affects approximately 6% to 7% of adults in the US and significantly impairs quality of life. Author William Chey, MD, of the University of Michigan joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss strategies for diagnosis and treatment of chronic, noninfectious diarrhea. Related Content: Chronic, Noninfectious Diarrhea

3月2日

•

20分
3月6日

AI Tools for Patients Have Arrived

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?

3月6日

•

6分
3日前

PrEP Prevents HIV—If Patients Can Get It

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "After a Decade of Progress Against HIV, PrEP Enters a Precarious Era." Related Content: After a Decade of Progress Against HIV, PrEP Enters a Precarious Era

3日前

•

6分
2月23日

Does This Patient Have Volume Overload? The Rational Clinical Examination

Accurate assessment of intravascular volume facilitates decisions about fluid management in patients with volume overload. Author Edmund A. Liles Jr, MD, of the University of Utah joins JAMA Associate Editor David Simel, MD, MHS, to discuss best evidence from physical exam findings including ultrasound, radiographs, and lab studies for determining volume overload in spontaneously breathing patients. Related Content: Does This Patient Have Volume Overload?

2月23日

•

19分
2月16日

Type 1 Diabetes: Diagnosis and Management

Type 1 diabetes affects approximately 2 million people in the US and 8.4 million people worldwide. Author Desmond Schatz, MD, of the University of Florida joins JAMA Deputy Editor Mary M. McDermott, MD, to discuss current evidence regarding diagnosis and treatment of type 1 diabetes. Related Content: Type 1 Diabetes

2月16日

•

17分
1月26日

IgA Nephropathy in Adults

IgA nephropathy is a chronic kidney disease involving deposition of IgA-containing immune complexes in the glomerulus, which often causes kidney failure within 10 to 20 years. Author Michelle Marie O'Shaughnessy, MB, BCh, BAO, MS, of Galway University joins JAMA Deputy Editor Kristin Walter, MD, MS, to discuss the symptoms, risk factors, diagnosis, treatment, and prognosis of IgA nephropathy in adults. Related Content: IgA Nephropathy in Adults

1月26日

•

27分
2月27日

Why the Low Carb vs Low Fat Debate Misses the Point

JAMA Medical News Associate Managing Editor Kate Schweitzer and Staff Writer Samantha Anderer discuss "In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health." Related Content: In the Low-Carb vs Low-Fat Debate, Study Suggests Food Quality Matters More for Heart Health

2月27日

•

4分
2月2日

Ovarian Cancer Prevention With Opportunistic Fallopian Tube Removal

Ovarian cancer may be prevented with removal of the fallopian tubes during pelvic or select abdominal surgery in eligible women. This procedure, opportunistic salpingectomy, can be offered to more eligible women. Author Jurgen M. Piek, MD, PhD, of the Catharina Cancer Institute discusses this and more with JAMA Deputy Editor Linda Brubaker, MD, MS. Related Content: Opportunistic Salpingectomy for Prevention of Tubo-Ovarian Carcinoma

2月2日

•

18分
2025/12/17

WHO Guideline on the Use and Indications of GLP-1 Therapies for the Treatment of Obesity in Adults

Obesity affects more than 1 billion people worldwide and is recognized by the World Health Organization as a chronic, relapsing disease. WHO recently published a guideline in JAMA on the use and indications of GLP-1 therapies for the treatment of #obesity in adults. Francesca Celletti, MD, PhD, and Ezekiel Emanuel, MD, PhD, join JAMA Editor in Chief Kirsten Bibbins-Domingo, PhD, MD, MAS, to discuss. Related Content: World Health Organization Guideline on the Use and Indications of Glucagon-Like Peptide-1 Therapies for the Treatment of Obesity in Adults

2025/12/17

•

34分

JAMA Network™ is a collection of 13 medical journals spanning specialties and general medicine. JN podcasts include Editor summaries, author interviews, conversations, clinical updates and more.

Webサイト

JAMA Network

トップ番組

トップエピソード

番組について